Matrix Medical Network (Matrix), a leader in delivering high quality, home-based health and care services, announced a new strategic partnership with CareNexa, LLC dba Molecular Testing Labs (MTL), a CLIA- and New York state-certified, CAP-accredited laboratory renowned for its innovation and quality in molecular diagnostics. The collaboration represents an additional step in Matrix's mission to improve health outcomes for patients and deliver greater value to clients.
Matrix selected MTL after a thorough evaluation of their advanced capabilities, high-quality standards and shared vision for delivering accessible care. This strategic decision brings several key enhancements that will improve the quality, flexibility and reliability of Matrix's in-home screening services:
"At Matrix, we're committed to improving lives and delivering high-quality patient-centered care, wherever people call home," said Catherine J. Tabaka, President & CEO of Matrix. "This partnership further demonstrates our commitment to safe and accurate testing and screening as an important element of whole-person care."
"By aligning MTL's premier lab capabilities with Matrix's comprehensive care model, we are now positioned to deliver superior clinical outcomes for the patients we care for, while ensuring enhanced operational outcomes for our clients," said Jeanette Richards, Senior Director, Clinical Excellence at Matrix.